Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.
The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson's disease (PD). Here, we explore the role of plasma apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promoter variation on plasma ApoA1 levels. Plasma ApoA1 and the single-nucleotide polymorphism, rs670, were assayed in a discovery cohort (cohort 1) of 301 PD patients, 80 normal controls (NCs), and 165 subjects with other neurodegenerative diseases, as well as a cohort (cohort 2) of 158 PD patients from a second clinical site. Additionally, rs670 was genotyped in a third cohort of 1,494 PD and 925 NC subjects from both clinical sites. Compared to both normal and disease controls, PD patients have lower plasma ApoA1 (P < 0.001 for both comparisons). Moreover, in PD patients, plasma ApoA1 levels are correlated with genotype at the APOA1 promoter polymorphism, rs670. Specifically, lower plasma ApoA1 levels were found in rs670 major allele (G) homozygotes in both cohort 1 (P = 0.009) and in a replication cohort (cohort 2; n = 158 PD patients; P = 0.024). Finally, evaluating rs670 genotype frequencies in 1,930 PD cases versus 997 NCs, the rs670 GG genotype shows a trend toward association (odds ratio: 1.1; P = 0.10) with PD. Our results are compatible with a model whereby circulating ApoA1 levels may be useful in risk-stratifying subjects for the development of PD, with higher ApoA1 levels suggesting relative protection. Future studies evaluating modulation of ApoA1 as a novel therapeutic strategy in PD are warranted. © 2014 International Parkinson and Movement Disorder Society.
['Swanson|Christine R|CR|', 'Li|Katherine|K|', 'Unger|Travis L|TL|', 'Gallagher|Michael D|MD|', 'Van Deerlin|Vivianna M|VM|', 'Agarwal|Pinky|P|', 'Leverenz|James|J|', 'Roberts|John|J|', 'Samii|Ali|A|', 'Gross|Rachel Goldmann|RG|', 'Hurtig|Howard|H|', 'Rick|Jacqueline|J|', 'Weintraub|Daniel|D|', 'Trojanowski|John Q|JQ|', 'Zabetian|Cyrus|C|', 'Chen-Plotkin|Alice S|AS|']
D000368:Aged D000483:Alleles D016632:Apolipoprotein A-I D015415:Biomarkers D015331:Cohort Studies D005260:Female D005787:Gene Frequency D020022:Genetic Predisposition to Disease D005838:Genotype D006720:Homozygote D006801:Humans D008297:Male D008875:Middle Aged D016017:Odds Ratio D010300:Parkinson Disease D020641:Polymorphism, Single Nucleotide D011401:Promoter Regions, Genetic
Apolipoprotein A1 Parkinson's disease genotype biomarker ApoA1